SOW
AVIR icon

State of Wyoming’s Atea Pharmaceuticals AVIR Stock Holding History

State of Wyoming’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-24,893
Closed -$83.4K – 1564
2023
Q1 		$83.4K Sell
24,893
-7,013
-22% -$28.4K 0.03% 875
2022
Q4 		$153K Buy
+31,906
New +$161K 0.05% 509
2022
Q2 		– Sell
-4,700
Closed -$34K – 1865
2022
Q1 		$34K Buy
+4,700
New +$31.9K 0.02% 1250
2021
Q4 		– Sell
-46
Closed -$2K – 1864
2021
Q3 		$2K Sell
46
-309
-87% -$8.57K ﹤0.01% 1150
2021
Q2 		$8K Buy
355
+85
+31% +$2.55K 0.01% 1033
2021
Q1 		$17K Buy
+270
New +$18.2K 0.03% 336

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State of Wyoming's AVIR Position: Q2 2023 in Review

State of Wyoming sold out of Atea Pharmaceuticals (AVIR) in Q2 2023, closing a stake of 24,893 shares — an estimated $83.4K sold.

State of Wyoming first reported a position in AVIR in Q1 2021 and held it in 6 quarters. The position peaked at $153K in Q4 2022. 133 funds tracked by Wall St. Rank hold AVIR as of Q2 2023.

  • State of Wyoming reported no remaining Atea Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • State of Wyoming sold 24,893 Atea Pharmaceuticals shares in Q2 2023, an estimated $83.4K.
  • State of Wyoming first reported a position in Atea Pharmaceuticals in Q1 2021 and held it in 6 quarters.
  • State of Wyoming's Atea Pharmaceuticals position peaked at $153K in Q4 2022.
  • 133 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q2 2023.

Based on State of Wyoming's 13F filing for Q2 2023, filed 14 Aug 2023.